Eisai / Biogen

Eisai / Biogen is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Eisai / Biogen products.

Drugs from Eisai / Biogen supported via NPP

BrandGenericCategoryIndication
LeqembilecanemabNeurology (Alzheimer)Alzheimer’s disease

How NPP access to Eisai / Biogen products works

Reserve Meds sources Eisai / Biogen products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Eisai / Biogen

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Eisai / Biogen.

Start a request

Start a request for a Eisai / Biogen product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp